A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
CRISPR-Cas9 gene editing can induce a p53 mediated damage response. Here the authors investigate the possibility of selection of pre-existing cancer driver mutations during CRISPR-Cas9 knockout based gene editing and identify KRAS mutants that may confer a selected advantage to edited cells.
Guardado en:
Autores principales: | Sanju Sinha, Karina Barbosa, Kuoyuan Cheng, Mark D. M. Leiserson, Prashant Jain, Anagha Deshpande, David M. Wilson, Bríd M. Ryan, Ji Luo, Ze’ev A. Ronai, Joo Sang Lee, Aniruddha J. Deshpande, Eytan Ruppin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5fe16eb955dc4e7db09618e84c592388 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
por: Kuoyuan Cheng, et al.
Publicado: (2021) -
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
por: Asmamaw M, et al.
Publicado: (2021) -
Engineering of CRISPR-Cas12b for human genome editing
por: Jonathan Strecker, et al.
Publicado: (2019) -
Optimization of genome engineering approaches with the CRISPR/Cas9 system.
por: Kai Li, et al.
Publicado: (2014) -
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
por: M. Martinez-Lage, et al.
Publicado: (2020)